AMAbdul Nashirudeen Mumuni

Abdul Nashirudeen Mumuni

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Abdul Nashirudeen Mumuni has a total of 56 co-authors. Here are the top co-authors by number of shared publications:

  • Eric Naab Manson

    Department of Medical Imaging, School of Allied Health Sciences, University for Development Studies, Tamale, Ghana

    2 shared publications
  • John McLean

    Department of Clinical Physics and Bioengineering , Queen Elizabeth University Hospital , Glasgow , UK

    2 shared publications
  • Jonathan Cavanagh

    Institute of Infection, Immunity and Inflammation , University of Glasgow , Glasgow , UK

    2 shared publications
  • A.R. Rafia

    Department of Medical Imaging, School of Allied Health Sciences, University for Development Studies, Tamale, Ghana

    1 shared publication
  • Abderrazek Zeraii

    Biophysics department, Higher Institute of Medical Technologies of Tunis, Tunisia

    1 shared publication
  • Abiodun Fatade

    Crestview Radiology Ltd, Lagos, Nigeria

    1 shared publication

Latest Publications

  • Open Access

    Could Ultrasonographic Measurements of the Umbilical Cord be a Predictor of Birth Weight? A Health Facility‐Based Cross‐Sectional Study

    by Swallah Alhaji Suraka, Abdul Nashirudeen Mumuni, Nathaniel Awentiirin Angaag, Larisa‐ Ioana Coman, Eric Kwasi Ofori

    Background: Factors such as maternal demographics, anthropometrics, health status, and lifestyle are known to have direct associations with newborn birth weight. However, there is an indication that umbilical cord size measured using ultrasonography could potentially be a predictor of birth weight. This study, therefore, aimed to investigate the relationship between umbilical cord measurements and birth weight in Ghana. Method: A prospective, cross‐sectional, quantitative approach was adopted for this study. A total of 107 patients were purposively sampled with an attrition rate of 9.3%, leading to 97 (90.7%) partaking in the study, aged between 17 and 41 years. The patients were recruited between 34 and 37 weeks of gestation during their routine antenatal care visit. Data was collected using a data sheet with some key parameters recorded, being: maternal age, gravida, parity, umbilical cord diameter (UCD), umbilical cord circumference (UCC) and umbilical cord area (UCA), which were manually entered into the IBM SPSS version 26. Results: The mean age recorded was 29.59 ± 4.83 years. The mean UCD, UCC and UCA were 1.53 ± 0.19 cm, 5.57 ± 0.41 cm and 1.86 ± 0.47 cm 2 , respectively. The Cronbach's alpha coefficient ( α ) was used to assess intra‐observer reliability, and it showed strong consistency and precision. The mean birth weight was 3.13 ± 0.27 kg. There were moderate positive correlations between UCD and birthweight ( r = 0.53, p < 0.01), UCC and birthweight ( r = 0.331, p < 0.001) and UCA and birthweight ( r = 0.52, p < 0.001). There were positive correlations between maternal demographics and UCD and maternal demographics and UCA. The study found no correlation between maternal demographics and UCC. Multiple regression analysis of the predictors of birth weights in the study population was conducted. The model as a whole was significant in predicting neonatal birth weights among the study participants at F (4, 92) = 20.731, p < 0.001. The final predictive equation of the model for predicting BW was given as: BW = 1.849 + 0.021 × maternal age + 0.031 × parity − 0.066 × UCC + 0.652 × UCD. Conclusion: The results suggest that umbilical cord size could be an important marker for fetal weight estimation. However, the less diverse small sample size and single‐centre design of the study limit the generalizability of the findings.

  • Open Access

    Establishment of baseline size-specific dose estimate (SSDE) for paediatric head computed tomography (CT) examinations

    by Hamza Sulemana, Abdul Nashirudeen Mumuni, Izre-Deen Osman Mohammed Abubakari

    Background: In recent times, size-specific dose estimate (SSDE) has been the ideal metric for accurate estimation of individual patient doses in computed tomography (CT) examinations. The objective of this study was to estimate patient radiation doses based on SSDE and the water-equivalent diameter (DW) as an effect tool for dose optimization in paediatric head CT at two facilities in Tamale Metropolis, in the northern region of Ghana. This is a preliminary retrospective study conducted on 57 paediatric patients (comprising 32 males and 25 females), aged newborns to 16 years old, who underwent head CT examinations. Patient head sizes were determined in terms DW, which was calculated by manual contouring the circumference of the CT images excluding the background to measure the region of interest (ROI) using the mid-slice axial CT images. SSDE was calculated as the product of CTDIvol and the size-specific conversion coefficients (CTDIvol, 16 to SSDE) obtained from the American Association of Physicists in Medicine (AAPM) Report 293. Results: At facility ‘A’, the median SSDE values for patients, aged 3 months to 1 year, 1 to 6 years, and older than 6 years were 46.1 mGy, 39.6 mGy, and 48.2 mGy, respectively. The corresponding CTDIvol values were 42.3 mGy, 39.1 mGy, and 51.7 mGy. Facility ‘B’ reported median SSDE values of 36.0, 39.2, and 43.8 mGy, with corresponding CTDIvol values of 28.7, 39.8, and 46.9 mGy for the same age categories. For all age groups, the two facilities showed significant differences in SSDE values (44.72 mGy vs. 39.77 mGy, p = 0.009) and CTDIvol values (45.72 mGy vs. 40.60 mGy, p = 0.03). Some of the age group doses were up to 25.3% in CTDIvol and 25.8% in SSDE higher than those found in published data. Conclusions: The SSDEs estimated showed significant variations between the two facilities, indicating a possible variability of scan protocols for paediatric head CT examinations. The SSDEs obtained in this study could be useful for optimization of paediatric routine head CT examinations.


  • Open Access

    Scan With Me: A Train-the-Trainer Program to Upskill MRI Personnel in Low- and Middle-Income Countries

    by Abdul Nashirudeen Mumuni, Katerina Eyre, Cristian Montalba, Aduluwa Harrison, Surendra Maharjan, Francis Botwe, Marina Fernandez Garcia, Abderrazek Zeraii, Matthias G. Friedrich, Abiodun Fatade, et al.


  • Brain glutathione and GABA+ levels in autistic children

    by Yulu Song, Kathleen E. Hupfeld, Christopher W. Davies‐Jenkins, Helge J. Zöllner, Saipavitra Murali‐Manohar, Abdul Nashirudeen Mumuni, Deana Crocetti, Vivek Yedavalli, Georg Oeltzschner, Natalie Alessi, et al.

    Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by social communication challenges and repetitive behaviors. Altered neurometabolite levels, including glutathione (GSH) and gamma‐aminobutyric acid (GABA), have been proposed as potential contributors to the biology underlying ASD. This study investigated whether cerebral GSH or GABA levels differ between a cohort of children aged 8–12 years with ASD (n = 52) and typically developing children (TDC, n = 49). A comprehensive analysis of GSH and GABA levels in multiple brain regions, including the primary motor cortex (SM1), thalamus (Thal), medial prefrontal cortex (mPFC), and supplementary motor area (SMA), was conducted using single‐voxel HERMES MR spectroscopy at 3T. The results revealed no significant differences in cerebral GSH or GABA levels between the ASD and TDC groups across all examined regions. These findings suggest that the concentrations of GSH (an important antioxidant and neuromodulator) and GABA (a major inhibitory neurotransmitter) do not exhibit marked alterations in children with ASD compared to TDC. A statistically significant positive correlation was observed between GABA levels in the SM1 and Thal regions with ADHD inattention scores. No significant correlation was found between metabolite levels and hyper/impulsive scores of ADHD, measures of core ASD symptoms (ADOS‐2, SRS‐P) or adaptive behavior (ABAS‐2). While both GSH and GABA have been implicated in various neurological disorders, the current study provides valuable insights into the specific context of ASD and highlights the need for further research to explore other neurochemical alterations that may contribute to the pathophysiology of this complex disorder.


  • Open Access

    Assessment of the Impact of Turbo Factor on Image Quality and Tissue Volumetrics in Brain Magnetic Resonance Imaging Using the Three-Dimensional T1-Weighted (3D T1W) Sequence

    by Eric Naab Manson, Stephen Inkoom, Abdul Nashirudeen Mumuni, Issahaku Shirazu, Adolf Kofi Awua

    Background. The 3D T1W turbo field echo sequence is a standard imaging method for acquiring high-contrast images of the brain. However, the contrast-to-noise ratio (CNR) can be affected by the turbo factor, which could affect the delineation and segmentation of various structures in the brain and may consequently lead to misdiagnosis. This study is aimed at evaluating the effect of the turbo factor on image quality and volumetric measurement reproducibility in brain magnetic resonance imaging (MRI). Methods. Brain images of five healthy volunteers with no history of neurological diseases were acquired on a 1.5 T MRI scanner with varying turbo factors of 50, 100, 150, 200, and 225. The images were processed and analyzed with FreeSurfer. The influence of the TFE factor on image quality and reproducibility of brain volume measurements was investigated. Image quality metrics assessed included the signal-to-noise ratio (SNR) of white matter (WM), CNR between gray matter/white matter (GM/WM) and gray matter/cerebrospinal fluid (GM/CSF), and Euler number (EN). Moreover, structural brain volume measurements of WM, GM, and CSF were conducted. Results. Turbo factor 200 produced the best SNR ( median = 17.01 ) and GM/WM CNR ( median = 2.29 ), but turbo factor 100 offered the most reproducible SNR ( IQR = 2.72 ) and GM/WM CNR ( IQR = 0.14 ). Turbo factor 50 had the worst and the least reproducible SNR, whereas turbo factor 225 had the worst and the least reproducible GM/WM CNR. Turbo factor 200 again had the best GM/CSF CNR but offered the least reproducible GM/CSF CNR. Turbo factor 225 had the best performance on EN (-21), while turbo factor 200 was next to the most reproducible turbo factor on EN (11). The results showed that turbo factor 200 had the least data acquisition time, in addition to superior performance on SNR, GM/WM CNR, GM/CSF CNR, and good reproducibility characteristics on EN. Both image quality metrics and volumetric measurements did not vary significantly ( p > 0.05 ) with the range of turbo factors used in the study by one-way ANOVA analysis. Conclusion. Since no significant differences were observed in the performance of the turbo factors in terms of image quality and volume of brain structure, turbo factor 200 with a 74% acquisition time reduction was found to be optimal for brain MR imaging at 1.5 T.


  • Spectral peak areas do not vary according to spectral averaging scheme used in functional MRS experiments at 3 T with interleaved visual stimulation

    by Abdul Nashirudeen Mumuni, John McLean, Gordon Waiter

    Brain response to visual stimulation can be probed quantitatively using functional magnetic resonance spectroscopy (fMRS), which relies on the blood oxygenation level dependent (BOLD) contrast mechanism. BOLD effect in fMRS is associated with changes in the areas, widths, and heights of the MR spectra. This study investigated the effect of spectral averaging scheme (NEX value) on BOLD changes in the spectra. Using a visual stimulus at 8 Hz in single and interleaved stimulation paradigms, the BOLD effects in spectra acquired from the occipital brain region of three healthy volunteers (mean age ± SD = 32.7 ± 3.5 years) were compared for two fMRS data sets acquired with two NEX values (“2” and “8”) available on a 3 T MR scanner. BOLD signal changes were estimated as percentage changes in spectral areas, heights, and widths of six cerebral metabolites and water using the SAGE software package (version 7). There was a general trend of lower BOLD effects with NEX = 8 in both stimulation paradigms. In the single stimulation paradigm, NEX = 8 was associated with significantly lower N-acetyl aspartate (NAA) spectral height (p = 0.03), creatine (p = 0.04) and choline (p = 0.02) spectral widths, and NAA (p = 0.03), water (p < 0.01), and glutamate (p = 0.02) spectral areas. In the interleaved stimulation paradigm, NEX = 8 was associated with significantly lower glutamate spectral height (p = 0.02), water (p = 0.03), and glutamine (p = 0.03) spectral widths, but there was no significant difference in all spectral areas between the two NEX values. Even though the two NEX values offered some differences in observable BOLD effects, their spectral areas were not significantly different in the interleaved visual stimulation experiments.

  • Open Access

    Peripheral inflammation is associated with alterations in brain biochemistry and mood: evidence from in vivo proton magnetic resonance spectroscopy study

    by Abdul Nashirudeen Mumuni, Rajeev Krishnadas, Jonathan Cavanagh

    Tumor necrosis factor (TNF)-α is a protein implicated in the prognosis of psoriatic arthritis (PsA), an autoimmune disease associated with episodes of clinical depression (CD). CD has been linked to abnormalities in the forebrain and subcortical structures, which can be probed noninvasively using proton magnetic resonance spectroscopy (1H-MRS). Thus, this 1H-MRS study assessed biochemical differences between healthy subjects and PsA patients in the frontal and bilateral hippocampal brain regions. Biochemical and mood responses in the anterior cingulate cortex and bilateral hippocampi following the administration of anti-TNF-α medication to the PsA patients were also assessed. Fifteen volunteers in each of the PsA and control groups participated in the study. Patients underwent MRS examination before and after 6–8 weeks of anti-TNF-α medication. Mood was assessed at baseline and after medication using the Beck’s Depression Inventory (BDI). Psychiatric symptoms were ruled out in all volunteers using the 12-item General Health Questionnaire. MRS studies were conducted using the PRESS sequence at 3 T. Spectral and statistical analyses were conducted using the LC Model and Minitab software, respectively. Metabolite levels were expressed as ratios, relative to the creatine peak. The PsA patients showed higher left hippocampal baseline Choline/Creatine ratio than controls (p = 0.014). After medication, decrease in frontal brain Choline/Creatine ratio was associated with decrease in BDI scores (r = 0.628; p = 0.025), while frontal brain NAA/Creatine ratio was significantly lower in the PsA patients compared to the controls (p = 0.023). No other significant differences were found in all comparisons, including metabolite ratios between the left and right hippocampi. The results of this study provide some evidence for biochemical alterations in the mood regulating segments of the brain, which has consequences for mood states of the affected patients.


  • A SWOT analysis of artificial intelligence in diagnostic imaging in the developing world: making a case for a paradigm shift

    by Abdul Nashirudeen Mumuni, Francis Hasford, Nicholas Iniobong Udeme, Michael Oluwaseun Dada, Bamidele Omotayo Awojoyogbe

    Diagnostic imaging (DI) refers to techniques and methods of creating images of the body’s internal parts and organs with or without the use of ionizing radiation, for purposes of diagnosing, monitoring and characterizing diseases. By default, DI equipment are technology based and in recent times, there has been widespread automation of DI operations in high-income countries while low and middle-income countries (LMICs) are yet to gain traction in automated DI. Advanced DI techniques employ artificial intelligence (AI) protocols to enable imaging equipment perceive data more accurately than humans do, and yet automatically or under expert evaluation, make clinical decisions such as diagnosis and characterization of diseases. In this narrative review, SWOT analysis is used to examine the strengths, weaknesses, opportunities and threats associated with the deployment of AI-based DI protocols in LMICs. Drawing from this analysis, a case is then made to justify the need for widespread AI applications in DI in resource-poor settings. Among other strengths discussed, AI-based DI systems could enhance accuracies in diagnosis, monitoring, characterization of diseases and offer efficient image acquisition, processing, segmentation and analysis procedures, but may have weaknesses regarding the need for big data, huge initial and maintenance costs, and inadequate technical expertise of professionals. They present opportunities for synthetic modality transfer, increased access to imaging services, and protocol optimization; and threats of input training data biases, lack of regulatory frameworks and perceived fear of job losses among DI professionals. The analysis showed that successful integration of AI in DI procedures could position LMICs towards achievement of universal health coverage by 2030/2035. LMICs will however have to learn from the experiences of advanced settings, train critical staff in relevant areas of AI and proceed to develop in-house AI systems with all relevant stakeholders onboard.